by Sowmya Viswanathan | Nov 30, 2017
The recent FDA approvals of Kymriah™ for the treatment of children and young adults with B-cell Acute Lymphoblastic Leukemia, and Yescarta™ to treat adults with certain types of non-Hodgkin lymphoma, and the unanimous endorsement by an FDA advisory committee of a gene...
by Samantha Yammine | Nov 23, 2017
With the extensive exploitation of regenerative medicine through the marketing and selling of unapproved stem cell “therapies” online, it was refreshing to hear an update about clinical trials for a legitimate stem cell therapy at the Till & McCulloch Meetings...
by Stacey Johnson | Oct 27, 2017
Before Jake Gyllenhaal starred in the 2001 comedy Bubble Boy, there was a 1976 version starring John Travolta called The Boy In The Plastic Bubble. Both movies were inspired by the lives of David Vetter, who had severe combined immunodeficiency (SCID), and Ted DeVita,...
by Stacey Johnson | Oct 20, 2017
In what feels like back-to-back news, the U.S. Food and Drug Administration (FDA) has approved two gene therapies for cancer. The actual announcements happened seven weeks apart, but for patients, manufacturers, investors and shareholders, it’s like Christmas – over...
by Stacey Johnson | Oct 13, 2017
If you’ve stumbled upon this blog thinking you will be reading about the attractive and talented cast of the popular 2016 TV show on NBC, I suspect you will be very disappointed. While there is video for you below, you will not see any rippling muscles and you don’t...
by Stacey Johnson | Aug 9, 2017
Although new to the field of science communication, Nathan Holwell has been involved in a variety of research during his undergraduate career and now in his graduate career. He has done research in drug delivery, gene delivery, biomaterials and diagnostic devices. His...
Comments